Bong Koh
Co-Founder @ Hypothesis
Chicago, United States
Bong Koh is a seed investor at Hypothesis in Chicago focused on Health Care and Apps. Bong Koh is Co-Founder and Investment Partner at Hypothesis.He attended Yale University.
- Total investments:
- 4
- Last investment:
- Lead investor:
- 25%
Last updated:
For AI agents: llms.txt
Industries Bong Koh invests in
Stages Bong Koh invests in
Countries Bong Koh invests in
Investment Focus
Industry
- Health Care 3 (75%)
- Apps 1 (25%)
- FinTech 1 (25%)
- Medical 1 (25%)
- Internet 1 (25%)
Stage
- Seed 2 (50%)
- Series C 1 (25%)
- Funding Round 1 (25%)
Investments
| Company | Description | Round | Links |
|---|---|---|---|
Morf Health
|
Morf Health is making it 10x faster for healthcare providers to setup and maintain integrations across their tech stack, e.g. easily structure data from patient intake and send to an EHR. We pull data out of the tools they use to deliver care and run the business, unify and normalize the data, and then send it to the tools that need it. | $3M / Seed / Nov 14, 2023 | |
CoverRight
|
CoverRight operates at the intersection of digital health and finance. The company provides a digital-first Medicare navigation experience where consumers can receive customized Medicare plan suggestions. CoverRight collaborates with experienced Insurance, Banking, Pharmacy and Healthcare Provider partners nationwide to create a digitally-drivenand personalized Medicare enrollment and health navigation experience. | $2.2M / Dec 12, 2022 | |
|
CoverRight
|
CoverRight operates at the intersection of digital health and finance. The company provides a digital-first Medicare navigation experience where consumers can receive customized Medicare plan suggestions. CoverRight collaborates with experienced Insurance, Banking, Pharmacy and Healthcare Provider partners nationwide to create a digitally-drivenand personalized Medicare enrollment and health navigation experience. | $2.2M / Seed / Dec 12, 2022 | |
RayzeBio
|
RayzeBio is focused on improving outcomes for people with cancer by harnessing the power of targeted radioisotopes. As the emerging leader in radiopharmaceuticals, RayzeBio is developing an innovative robust pipeline against validated oncology drug targets to deliver radioisotopes that emit alpha particles such as Actinium-225. | $108M / Series C / Jun 15, 2021 |
Co-Investors
About Hypothesis
Hypothesis Studio is a venture capital and firm focused on emerging markets and ecosystems. In addition, they bringing their collective networks which bring experience from category-defining entities such as Facebook, Google, WebMD, Tencent, Groupon, YouTube, Uber, Amazon, Snapchat, and Yahoo. They partner with entrepreneurs who mission-driven,scrappy, product-focused, passionate, and relentless.Hypothesis Studio works with mission-driven founders who trying to make a big impact in sectors including healthcare tech, education tech, agricultural tech, real asset management, enterprise, logistics, fintech, mobile, IoT, and software services.
Hypothesis Contacts
| Name | Phone | Socials | |
|---|---|---|---|
|
Bong Koh
Co-Founder
|
|||
John Ryu
Partner
|
|||
James Smits
Venture Partner
|
|||
Peter Brack
Managing Partner
|
|||
1 more contact available
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!
Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Recommended lists
FAQ
What does Bong Koh invest in?
Bong Koh invests primarily in Health Care, Apps and FinTech startups, most often at Seed and Series C stage. Most of the 4 investments tracked by Shizune back companies in United States. The Investment Focus section breaks down every industry, stage and country in the portfolio.
When did Bong Koh last invest?
The most recent investment recorded for Bong Koh closed in Nov 2023. Shizune tracks 4 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!
Continue with Google
Continue with LinkedIn
